Volume | 460,348 |
|
|||||
News | - | ||||||
Day High | 26.02 | Low High |
|||||
Day Low | 24.06 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Avidity Biosciences Inc | RNA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
24.20 | 24.06 | 26.02 | 24.16 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
9,180 | 460,348 | $ 25.15 | $ 11,576,618 | - | 4.825 - 27.66 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:59:09 | 1 | $ 25.602 | USD |
Avidity Biosciences (RNA) Options Flow Summary
Avidity Biosciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.03B | 79.72M | - | 9.56M | -212.22M | -2.66 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Avidity Biosciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RNA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 23.69 | 26.02 | 22.24 | 23.42 | 898,425 | 1.91 | 8.06% |
1 Month | 23.60 | 27.66 | 21.56 | 24.65 | 1,040,908 | 2.00 | 8.47% |
3 Months | 12.30 | 27.66 | 11.23 | 20.50 | 1,166,923 | 13.30 | 108.13% |
6 Months | 5.35 | 27.66 | 4.825 | 13.38 | 1,283,272 | 20.25 | 378.50% |
1 Year | 16.40 | 27.66 | 4.825 | 11.94 | 1,147,258 | 9.20 | 56.10% |
3 Years | 21.50 | 29.59 | 4.825 | 15.36 | 787,991 | 4.10 | 19.07% |
5 Years | 26.50 | 37.46 | 4.825 | 16.42 | 671,623 | -0.90 | -3.40% |
Avidity Biosciences Description
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. |